Challenges and potentials of developing domperidone into the transdermal delivery
Penulis/Author
Dr. apt. Sekar Ayu Pawestri, S.Farm. (1); Prof. Dr. apt. Akhmad Kharis Nugroho, S.Si., M.Si. (2); Prof. Dr.rer.nat. apt. Raden Rara Endang Lukitaningsih, S.Si., M.Si. (3); Dr. Purwantiningsih, S.Si., M.Si., Apt. (4)
Tanggal/Date
27 2022
Kata Kunci/Keyword
Abstrak/Abstract
Oral domperidone is widely prescribed in nausea treatment. The low bioavailability of oral domperidone makes a patient take the drug more frequently, even though some patients have difficulty swallowing the drug when suffering nausea. Recently, the drug formulation development for transdermal delivery systems is expected to increase in the future. Practical and increase patient comfortable is the notable advantages of using transdermal dosage form. Domperidone is currently being studied into various pharmaceutical dosage forms with the transdermal route. This present article provides summaries of the challenges also the current formulation development of domperidone which shows the potential of domperidone in transdermal delivery.
Rumpun Ilmu
Farmasetika dan Teknologi Farmasi
Bahasa Asli/Original Language
English
Level
Nasional
Status
Dokumen Karya
No
Judul
Tipe Dokumen
Aksi
1
Universitas Gadjah Mada Mail - [farmaseutik] Letter of Acceptance.pdf
Bukti Accepted
2
74154-279735-1-PB.pdf
Bukti Published
3
Bukti Korespondensi MF.pdf
[PAK] Bukti Korespondensi Penulis
4
jurnal_Farmaseutik-Sekar.pdf
[PAK] Full Dokumen
5
Challenges and potentials of developing domperidone into the transdermal delivery.pdf